Application of Magnetic Nanoparticles for Rapid Detection and In Situ Diagnosis in Clinical Oncology
Open Access
Abstract
Screening, monitoring, and diagnosis are critical in oncology treatment. However, there are limitations with the current clinical methods, notably the time, cost, and special facilities required for radioisotope-based methods. An alternative approach, which uses magnetic beads, offers faster analyses with safer materials over a wide range of oncological applications. Magnetic beads have been used to detect extracellular vesicles (EVs) in the serum of pancreatic cancer patients with statistically different EV levels in preoperative, postoperative, and negative control samples. By incorporating fluorescence, magnetic beads have been used to quantitatively measure prostate-specific antigen (PSA), a prostate cancer biomarker, which is sensitive enough even at levels found in healthy patients. Immunostaining has also been incorporated with magnetic beads and compared with conventional immunohistochemical methods to detect lesions; the results suggest that immunostained magnetic beads could be used for pathological diagnosis during surgery. Furthermore, magnetic nanoparticles, such as superparamagnetic iron oxide nanoparticles (SPIONs), can detect sentinel lymph nodes in breast cancer in a clinical setting, as well as those in gallbladder cancer in animal models, in a surgery-applicable timeframe. Ultimately, recent research into the applications of magnetic beads in oncology suggests that the screening, monitoring, and diagnosis of cancers could be improved and made more accessible through the adoption of this technology.Keywords
This publication has 78 references indexed in Scilit:
- Standardization of sample collection, isolation and analysis methods in extracellular vesicle researchJournal of Extracellular Vesicles, 2013
- Extracellular vesicle sizing and enumeration by nanoparticle tracking analysisJournal of Extracellular Vesicles, 2013
- Deposition of superparamagnetic iron‐oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injectionHistopathology, 2012
- Exosome removal as a therapeutic adjuvant in cancerJournal of Translational Medicine, 2012
- Development of an Ultrasound-emitting Device for Performing Rapid Immunostaining ProceduresJournal of Histochemistry & Cytochemistry, 2010
- High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma PatientsPLOS ONE, 2009
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurgical Oncology, 1993
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992